25. Denis Ph., Lerebours E. Study of the long-term tolerance of Forlax in 16 patients treated for an average of 17 months for chronic constipation. Medicine & Chirurgie Digestives 1996; 25:7-16.
26. Черемушкин С. В., Кучерявый Ю. А., Гончаренко А. Ю. и др. Ретроспективная оценка эффекта последействия при лечении хронического запора. Врач 2013; 3:58-62 [Cheremushkin S.V., Kucheryavy Yu.A., Goncharenko A.Yu. et al. Retrospective efficacy assessment of chronic constipation treatment aftereffect. Vrach 2013; 3:58-62].
27. Буторова Л. И. Профилактика и лечение хронического запора комплексными пребиотическими препаратами. СПб; 2013. 19 с. [Butorova L.I. Prevention and treatment of chronic constipation by combined prebiotic agents. St. Petersburg; 2013. 19 p.].
28. Bosshard W., Dreher R., Schnegg J., Bula C. The reatment of chronic constipation in elderly people: an update. Drugs Aging 2004; 21 911-30.
29. Stanghellini V., Vandeplassche L., Kerstens R. Best response distribution of 12-week treatment with prucalopride (RESOLOR) in patients with chronic constipation: combined results of three randomized, double-blind, placebo-controlled phase III trials. Gut 2011; 60(Suppl. 1):A159-A160.
30. Camilleri M. et al. Clinical trial: the efficacy of openlabel prucalopride treatment in patients with chronic constipation -- follow-up of patients from the pivotal studies. Aliment Pharmacol Ther 2010; 32(9):1113-23.
31. Еrment C. A., Bastawrous A. L., Morin N. A. et al. Practice parameters for the evaluation and management of constipation. Dis Colon Rectum 2007; 50:2013-22. worldgastroenterology.org/guidelines/global-guidelines/constipation.